Aesthetic Surgery Journal
An Analysis of Safety Data from Five Phase III Clinical Trials on the Use of Botulinum Neurotoxin Type A-ABO for the Treatment of Glabellar Lines
Mark Rubin, MD; Jeffrey Dover, MD, FRCPC; Corey Maas, MD; and Mark Nestor, MD, PhD


Back to Blog

Welcome to Excellence Providing a luxury experience & beautiful results.

Schedule a Consultation
Contact us media
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (415) 567-7000.
Contact Us